Research progress on anti-tumor and tumor immunity of marine natural products / 药学学报
Zi-jun OUYANG; Xiao-fan SUN; Hai-yan SUN; Yang SUN.
Acta Pharmaceutica Sinica
; (12): 2642-2653, 2022.
Artículo
en Zh
| WPRIM | ID: wpr-941518
In recent years, the oceans have provided an important source of highly promising new anti-tumor drugs for innovation and screening, with approximately 56% of biologically active compounds being discovered to have anti-tumor effects each year. In this study, we classified and summarized the approved drugs of marine origin in terms of anti-tumor therapy, and firstly, we briefly overviewed the role of the immune system in cancer pathogenesis and discussed the current dilemma of cancer immunotherapy and highlighted the main anti-tumor targets of marine drugs. Further, with a focus on tumor immunity, we classified and outlined the history of currently approved marine original drugs by species origin, structural features, relevant pathways, and clinical application and therapy. Lastly, the limitations of current marine drug research were discussed, as well as prospects and trends in new drug development.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados